The Need And Benefit of Implementing Telemedicine in Clinical Practice

Burguera, Bartolomé; Pantalone, Kevin M.; Griebeler, Marcio L.; Lansang, M. Cecilia; Rao, P L S D Malleswara; Kashyap, Sangeeta R.; Deimer, Danielle; Zhao, Karen; Makin, Vinni; Hamaty, Marwan; Zimmerman, Robert S.; Gambino, Ronald R.; Pace, Angela; Fink, J.S.; Jugler, Michael; Piel, Christopher; Siperstein, Allan

doi:10.4158/ep-2020-0205

Cited by 5 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As an increase of environmental stressors and other factors led to weight gain among Americans [ 22 ], the management of obesity became an important part of medical care. Telehealth has the potential to soon become the new standard of care [ 23 , 24 ], and studies like ours demonstrate that obesity care, including a combination of behavioral and pharmacological interventions, can be effectively delivered. Although the number of the patients in our study was relatively small, the study was appropriately powered to demonstrate noninferior weight loss with virtual versus in‐person care.…”

Section: Discussionmentioning

confidence: 99%

The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in‐person encounters

Griebeler

Butsch

Rodriguez

et al. 2022

Obesity

Self Cite

View full text Add to dashboard Cite

Objective: This study aimed to demonstrate noninferiority using telehealth in treating obesity with phentermine in patients with BMI ≥ 27 kg/m 2 with comorbidities or BMI ≥ 30 compared with the standard in-person approach over a 90-day period.Methods: A 12-week, randomized, prospective, single-center, open label trial compared the use of virtual visits versus in-person visits for the treatment of obesity using phentermine. The primary end point was percentage mean change in body weight from baseline to 12 weeks. A noninferiority approach assuming a 3% noninferiority region was used to assess effect size differences. Results:The weight loss in the virtual visit arm was noninferior to the in-person arm at all time points. At 12 weeks, the mean change in weight was À6.5% among the virtual group and À7.7% among the in-person group. In addition, 65% of virtual patients and 71% of in-person patients demonstrated a weight reduction of at least 5%. There was no difference in medication tolerance, adherence, and compliance.Conclusions: These results indicate that the virtual obesity pharmacotherapy visits in adults aged 18 to 65 years prescribed phentermine are effective and noninferior in achieving meaningful weight loss after 12 weeks. Future clinical trials are needed to better assess the effectiveness of televisits for obesity pharmacotherapy.

show abstract

Section: Discussionmentioning

confidence: 99%

The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in‐person encounters

Griebeler

Butsch

Rodriguez

et al. 2022

Obesity

Self Cite

View full text Add to dashboard Cite

show abstract

“…Gli autori hanno adattato la nota piattaforma Zoom alle esigenze cliniche e formative, coinvolgendo un medico, altre figure professionali (infermieri), una sala d’attesa virtuale ospitante studenti o specializzandi e/o il gruppo multidisciplinare di specialisti, secondo una procedura già prefigurata nel 2018 nel Regno Unito dal Royal College of Physicians nel documento Outpatient: the future [ 28 ]. L’esigenza di definire percorsi metodologici utili ad attuare questa innovativa e, per certi aspetti, anomala procedura atta a prendersi cura di un problema di salute, era da tempo avvertita e diversi studi sono stati dedicati a comprendere e definire le criticità nell’implementazione di modelli di e-health [ 5 , 6 ], a favorire il superamento di barriere e facilitare l’implementazione della consultazione specialistica telematica dopo l’irrompere della pandemia [ 7 ].…”

Section: L’ambulatorio Virtualeunclassified